MRC2/uPARAP rHuz mAb (Ref: Copenhagen Rigshospitalet patent)
Application
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Reactivity
Human
Target
| Target Name | MRC2 / CD280 |
| Target Uniprot | Q9UBG0 |
Overview
| Catalog# | BIO0363SM |
| Product Name | Anti-human MRC2 / CD280 (Copenhagen Rigshospitalet patent Anti-uPARAP Biosimilar) |
Specifications
| Conjugation | None |
| Formulation | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| Storage | For long term storage, the produce should be stored at -20℃ or lower. |
| Reconstitution | Dissolve with sterile ddH2O |
| Concentration | Lot Dependent |
| Isotype | Human IgG1 |
| Calculated M.W. | 145.28 kDa |
| Endotoxin | <0.001 EU/ug |
| Expression System | CHO |
| Purification | Protein A |
Frequently asked questions
Which applications is MRC2/uPARAP rHuz mAb (Ref: Copenhagen Rigshospitalet patent) (BIO0363SM) validated for, and at what dilution?
BIO0363SM is validated for In Vivo Research.